Explore

Rapid Read Rapid Read
Teal Health's At-Home Cervical Cancer Test Gains FDA Approval, Expands Access for Women

Teal Health's At-Home Cervical Cancer Test Gains FDA Approval, Expands Access for Women

Teal Health has developed an at-home cervical cancer screening test, which has been approved by the U.S. Food and Drug Administration (FDA). This test allows women aged 25 to 65 across the United States to collect a vaginal sample at home and send it to a lab for analysis. The test has shown a 96% accuracy rate in identifying pre-cancer, comparable to traditional in-office tests. The approval and subsequent rollout of this test mark a significant advancement in women's health, providing a convenient and private option for cervical cancer screening. The initiative aligns with efforts to eliminate cervical cancer, which the World Health Organization (WHO) has identified as an eliminable disease due to advancements in diagnostics and vaccination.
Rapid Read Rapid Read
C-Reactive Protein Identified as Superior Predictor of Heart Disease Risk

C-Reactive Protein Identified as Superior Predictor of Heart Disease Risk

Recent studies have identified C-reactive protein (CRP) as a more accurate predictor of heart disease risk than cholesterol levels. CRP, a marker of inflammation produced by the liver, has been shown to better predict heart attacks and strokes. The American College of Cardiology now recommends universal screening of CRP levels alongside cholesterol. Elevated CRP levels indicate increased inflammation and higher heart disease risk. Lifestyle factors such as diet and exercise can influence CRP levels, highlighting the importance of comprehensive risk assessment in heart disease prevention.
Rapid Read Rapid Read
CancerCheck and Evexia Partner to Enhance Early Cancer Detection Nationwide

CancerCheck and Evexia Partner to Enhance Early Cancer Detection Nationwide

Cancer Check Labs has announced a strategic partnership with Evexia Diagnostics to improve early cancer detection across the United States. The collaboration involves CancerCheck, a multi-cancer early detection test that uses a minimally invasive blood test to extract whole circulating tumor cells (CTCs). This test allows a board-certified pathologist to deliver a detailed pathology report. Unlike other tests that rely on biomarkers or DNA, CancerCheck isolates whole CTCs, providing a more accurate diagnosis. The partnership with Evexia will leverage its extensive lab network to make CancerCheck more accessible to clinicians and patients, offering the test through in-office or at-home blood collection. This initiative aims to enhance early cancer detection, potentially identifying cancer as early as Stage 0.
Rapid Read Rapid Read
NC Parents and Doctors Advocate for Insurance Coverage of Life-Saving Biomarker Testing

NC Parents and Doctors Advocate for Insurance Coverage of Life-Saving Biomarker Testing

In North Carolina, parents and doctors are advocating for insurance coverage of biomarker testing, which they argue is crucial for tailoring cancer treatments. Ashley Fannin, a pediatric oncology nurse, shared her experience with her son Mason, whose treatment for leukemia was guided by biomarker testing. House Bill 567, supported by the American Cancer Society Cancer Action Network and other organizations, seeks to mandate insurance coverage for these tests. While the bill passed the state House, it faces challenges in the Senate due to existing legislation requiring the repeal of other services for new coverage mandates.
AP News AP News
US overdose deaths fell again in 2025, but some worry about policy and drug supply changes

US overdose deaths fell again in 2025, but some worry about policy and drug supply changes

About 70,000 Americans died of drug overdoses last year — about 14% fewer than the previous year
AP News AP News
NASA's Psyche spacecraft buzzing Mars on its way to a rare metal asteroid

NASA's Psyche spacecraft buzzing Mars on its way to a rare metal asteroid

A NASA spacecraft chasing a rare metal asteroid is swinging past Mars for a gravity boost
AP News AP News
Justice Department accuses Yale medical school of illegally using race in admissions

Justice Department accuses Yale medical school of illegally using race in admissions

The Justice Department is accusing Yale University of illegally considering race in its medical school admissions
Rapid Read Rapid Read
Julian Lennon Discloses Coronary Heart Disease and Pre-Diabetes Diagnosis

Julian Lennon Discloses Coronary Heart Disease and Pre-Diabetes Diagnosis

Julian Lennon, the eldest son of John Lennon, has publicly revealed his diagnosis of coronary heart disease and pre-diabetes. In a candid Instagram post, Lennon urged his followers to prioritize their health by getting regular check-ups, emphasizing the importance of early detection. Despite these health challenges, Lennon expressed optimism about reversing some of the damage and maintaining a long, healthy life. He also expressed gratitude towards the medical professionals who have supported him. This revelation follows a previous health scare in 2020 when Lennon had a cancerous mole removed. Lennon, who has inspired several Beatles songs, continues to be active in the music industry, having released his seventh studio album, 'Jude,' in 2022.
AP News AP News
As Trump targets offshore wind, a look at the global industry by the numbers

As Trump targets offshore wind, a look at the global industry by the numbers

President Donald Trump is stopping offshore wind projects in the United States, just as the industry was poised to grow significantly
Rapid Read Rapid Read
New Study Suggests At-Home Fingerprick Test Could Identify Alzheimer's Risk Early

New Study Suggests At-Home Fingerprick Test Could Identify Alzheimer's Risk Early

A recent study published in Nature Communications has introduced a potential breakthrough in Alzheimer's disease detection through a simple at-home fingerprick blood test. This test aims to identify individuals at higher risk of Alzheimer's-related cognitive decline without the need for a clinic visit. The study involved 174 participants, ranging from cognitively healthy adults to those with mild cognitive impairment and Alzheimer's dementia. Participants used at-home kits to collect blood samples, which were then analyzed for biomarkers linked to Alzheimer's, such as p-tau217 and GFAP. The results showed that higher levels of these biomarkers correlated with poorer memory and cognitive function, suggesting the test's reliability in identifying individuals who may need further examination. This approach could revolutionize dementia care by allowing earlier detection and intervention, potentially giving individuals more time to make lifestyle changes or pursue emerging therapies.
AP News AP News
Trump administration will join a prayer gathering criticized for promoting Christian nationalism

Trump administration will join a prayer gathering criticized for promoting Christian nationalism

President Donald Trump and several top administration officials are joining with a cast of mostly conservative Christian clergy this Sunday for a prayer gathering
Trendline Trendline
Elton John Performs at Breast Cancer Research Foundation Gala, Raises $9 Million

Elton John Performs at Breast Cancer Research Foundation Gala, Raises $9 Million

Elton John Performs at Breast Cancer Research Foundation Gala, Raises $9 Million